| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.35% | 2025-09-30 |
| 2 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.35% | 2025-08-20 |
| 3 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.35% | 2025-06-30 |
| 4 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2025-03-31 |
| 5 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2024-12-31 |
| 6 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2024-09-30 |
| 7 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2024-06-30 |
| 8 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2024-05-15 |
| 9 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2024-03-31 |
| 10 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2023-12-31 |
| 11 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2023-09-30 |
| 12 | 恒瑞医药 | 95275.23 | 减持 | 流通A股 | 14.94% | 2023-06-30 |
| 13 | 恒瑞医药 | 95300 | 增持 | 流通A股 | 14.94% | 2023-05-15 |
| 14 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2023-03-31 |
| 15 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2022-12-31 |
| 16 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2022-09-30 |
| 17 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2022-06-30 |
| 18 | 恒瑞医药 | 95275.23 | 未变 | 14.94% | 2022-03-31 | |
| 19 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.94% | 2022-03-11 |
| 20 | 恒瑞医药 | 95275.23 | 未变 | 流通A股 | 14.9% | 2021-12-31 |
| 21 | 恒瑞医药 | 95275.23 | 未变 | 14.89% | 2021-09-30 | |
| 22 | 恒瑞医药 | 95275.23 | 增持 | 14.89% | 2021-06-30 | |
| 23 | 恒瑞医药 | 79396.03 | 未变 | 流通A股 | 14.89% | 2021-03-31 |
| 24 | 恒瑞医药 | 79396.03 | 未变 | 流通A股 | 14.89% | 2020-12-31 |
| 25 | 恒瑞医药 | 79396.03 | 未变 | 流通A股 | 14.96% | 2020-09-30 |
| 26 | 恒瑞医药 | 79396.03 | 增持 | 14.96% | 2020-06-30 | |
| 27 | 恒瑞医药 | 66163.35 | 未变 | 14.96% | 2020-03-31 | |
| 28 | 恒瑞医药 | 66163.35 | 未变 | 14.96% | 2019-12-31 | |
| 29 | 恒瑞医药 | 66163.35 | 减持 | 14.96% | 2019-09-30 | |
| 30 | 恒瑞医药 | 66913.35 | 新进 | 15.13% | 2019-06-30 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.355% | 2025-09-30 |
| 2 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.355% | 2025-08-20 |
| 3 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.355% | 2025-06-30 |
| 4 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2025-03-31 |
| 5 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2024-12-31 |
| 6 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2024-09-30 |
| 7 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2024-06-30 |
| 8 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2024-05-15 |
| 9 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2024-03-31 |
| 10 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2023-12-31 |
| 11 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2023-09-30 |
| 12 | 恒瑞医药 | 95275.23 | 减持 | 境内法人股 | 14.947% | 2023-06-30 |
| 13 | 恒瑞医药 | 95300 | 增持 | 流通A股 | 14.95% | 2023-05-15 |
| 14 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2023-03-31 |
| 15 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2022-12-31 |
| 16 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2022-09-30 |
| 17 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2022-06-30 |
| 18 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2022-03-31 |
| 19 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2022-03-11 |
| 20 | 恒瑞医药 | 95275.23 | 未变 | 境内法人股 | 14.936% | 2021-12-31 |
| 21 | 恒瑞医药 | 95275.23 | 未变 | A股 | 14.96% | 2021-09-30 |
| 22 | 恒瑞医药 | 95275.23 | 增持 | 境内法人股 | 14.963% | 2021-06-30 |
| 23 | 恒瑞医药 | 79396.03 | 未变 | A股 | 14.96% | 2021-03-31 |
| 24 | 恒瑞医药 | 79396.03 | 未变 | A股 | 14.99% | 2020-12-31 |
| 25 | 恒瑞医药 | 79396.03 | 未变 | A股 | 14.99% | 2020-09-30 |
| 26 | 恒瑞医药 | 79396.03 | 增持 | A股 | 14.99% | 2020-06-30 |
| 27 | 恒瑞医药 | 66163.35 | 未变 | A股 | 14.99% | 2020-03-31 |
| 28 | 恒瑞医药 | 66163.35 | 未变 | A股 | 15.02% | 2019-12-31 |
| 29 | 恒瑞医药 | 66163.35 | 减持 | A股 | 15.02% | 2019-09-30 |
| 30 | 恒瑞医药 | 66913.35 | 新进 | 15.13% | 2019-06-30 |
![]() |
![]() |